

Roll over image to zoom in
Pharmaxel (Dasatinib) 70mg online
$599.00
Status: In stock
A kinase inhibitor indicated for newly diagnosed adults with Philadelphia chromosome-positive chronic myeloid leukaemia in chronic phase. It is also indicated for adults with chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib, and for adults with Ph+ acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.
Dasatinib is a kinase inhibitor indicated for the treatment of
adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
599.00 per 60 Tablets
- newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
- adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.
adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
599.00 per 60 Tablets













